The report "Stem Cell Assay Market by Type (Viability,
Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic),
Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines,
Drug Development), End User - Forecast to 2021"The global stem cell assay market is expected to reach USD 1,363.3
Million by 2021 from USD 536.6 Million in 2016, at a CAGR of 20.5% from 2016 to
2021.
Browse 73 market
data Tables and 93 Figures spread through 182 Pages and in-depth TOC on "Stem Cell Assay Market “
Early buyers
will receive 10% customization on This report.
Market growth
can be attributed to the high prevalence of chronic diseases, increasing investment
in research related activities, and technological advancements. However,
stringent regulatory policies and high cost of stem cell based therapies are
major factors restraining the growth of this market.
In this report, the global stem cell assay market has been
segmented based on type of assay, by kits, by detection, by instruments, by
application, end-user, and region.
On the basis of type, the market has been segmented into
viability/cytotoxicity, isolation & purification, cell identification, proliferation,
differentiation, function and apoptosis. The viability/cytotoxicity segment is
expected to account for the largest share of the market in 2016. The high
growth in this segment is primarily attributed to the increasing focus of the
pharmaceutical industries on drug screening which resulted in the increasing
the demand for stem cell assays.
Based on kits, the stem cell assay market has been segmented into
adult stem cell kits and human embryonic stem cell kits. The adult stem cell
kits are further segmented into mesenchymal stem cell kits, induced pluripotent
stem cell kits (IPSCs), hematopoietic stem cell kits, umbilical cord stem cell
kits and neuronal stem cell kits. The adult stem cell kits segment is projected
to witness the highest CAGR from 2016 to 2021. The high growth in this segment
can be primarily attributed to the effectiveness of this type of kits in cell
analysis.
Based on application, the global stem cell assay market is
segmented into regenerative medicine & therapy development, drug discovery
and development and clinical research. The regenerative medicine & therapy
development segment is further segmented into orthopedic & musculoskeletal,
spine, cardiovascular, oncology, central nervous system, dermatology, diabetes
and others. The regenerative medicine & therapy development segment is
projected to witness the highest growth rate during the forecast period due to
the increase in incidences of chronic diseases which further leads to the
increased demand for regenerative medicines.
The Sample Report For This Report@
Geographically, the
stem cell assay market is dominated by North America, followed by Europe, the
Asia-Pacific region, and the Rest of the World (RoW). Growth in the North
American region is primarily driven by the increasing incidence and prevalence
of chronic diseases and increasing patient pool in North American countries.
The major players in
the global stem cell assay market are GE Healthcare (U.K.), Promega Corporation
(U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Cell
Biolabs, Inc. (U.S.), Hemogenix Inc. (U.S.), STEMCELL Technologies Inc. (CA),
Bio-Rad Laboratories, Inc (U.S.), Bio-Techne Corporation (U.S.), and Cellular
Dynamics International, Inc. (U.S.).
Get The PDF Brochure For This Report@
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’
revenues. Currently servicing 5000 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701
Pike Street
Suite
2175, Seattle,
WA
98101, United States
Tel:
1-888-600-6441
No comments:
Post a Comment